Cancer Therapy News and Research

RSS

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.

12 Sep 2013

Personalized treatment may be effective in wild type cancers

As a woman in her mid-forties who didn't smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.

11 Sep 2013

Research finding could lead to better solutions for cancer, anti-viral treatments

Medical scientists at the University of Alberta have made a key discovery about how the immune system kills healthy cells while attacking infections. This finding could one day lead to better solutions for cancer and anti-viral treatments.

11 Sep 2013

Discovery opens doors for developing new therapies to eradicate tumor cells, combat infections

Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.

11 Sep 2013

Astrazeneca, Hadasit Launch Drug Discovery Alliance

...

10 Sep 2013

Novel viral therapy to treat specific types of cancer in children

Parents do everything they can to protect their children against all of the nasty germs floating around classrooms across the country this time of year. Doctors and researchers at Nationwide Children's Hospital, however, are looking into how those same types of common viruses can actually help treat a child who is diagnosed with certain cancers.

10 Sep 2013

Biologists identify two pathways via which chromosomes are rearranged

Biologists reported today in Nature that they have identified two pathways through which chromosomes are rearranged in mammalian cells. These types of changes are associated with some cancers and inherited disorders in people.

10 Sep 2013

Study suggests expanded screening in younger women greatly reduces breast cancer mortality rate

A new analysis published online Sept. 9 in Cancer confirms the need for greater use of annual mammography in women ages 40-49 as recommended by the American Cancer Society, American Congress of Obstetricians and Gynecologists (ACOG), American College of Radiology and Society of Breast Imaging for all women 40 and older.

10 Sep 2013

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

10 Sep 2013

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

Citing the hardships certain to be faced by a population of California cancer patients on strained incomes, the National Patient Advocate Foundation (NPAF), a national non-profit organization providing the patient voice for legislative reform at the state and federal levels, pulled its support for AB 219 following amendments passed in the California state senate yesterday that would prohibitively increase the co-pay for oral cancer treatment.

7 Sep 2013

Enzymatics buys Boulder-based ArcherDx

Enzymatics, Inc., a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment.

7 Sep 2013

New flexible microneedle patch allows drugs to deliver directly through skin

An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.

7 Sep 2013

TSRI scientists identify involvement of angiomotin protein in cancer

A team led by scientists from The Scripps Research Institute have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth.

6 Sep 2013

Myeloid derived suppressor cells provide niche where cancer stem cells survive

The immune system is normally known for protecting the body from illness. But a subset of immune cells appear to be doing more harm than good.

6 Sep 2013

Greenwich Hospital's new radiation oncology therapy gives renewed hope to HRPC patients

At the end of July, Greenwich became the only hospital in New York City, Westchester and Fairfield counties to offer Xofigo, commonly referred to as Radium 223, a new radiation oncology therapy that is giving renewed hope to patients with stage 4 hormone-refractory prostate cancer.

6 Sep 2013

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

A team led by scientists from The Scripps Research Institute (TSRI) have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth. The findings could point to a new approach to cancer treatment.

5 Sep 2013

£13M partnership to accelerate cancer-focused drug discovery launched by Queen's and Almac Discovery

A new -13 million partnership to accelerate cancer-focused drug discovery in Northern Ireland has been launched by Enterprise Minister Arlene Foster MLA.

5 Sep 2013

CureDiva announces official launch of online breast cancer solutions store

CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.

4 Sep 2013

Scientists identify protein that blocks death of high-risk acute lymphoblastic leukemia cells

St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective method of killing tumor cells. The findings appear in the August 29 edition of the journal Blood.

30 Aug 2013

Virtual surgical planning technologies for most challenging facial reconstruction cases

Virtual surgical planning technologies give surgeons a powerful new tool for their most challenging facial reconstruction cases, reports a paper in the September issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons (ASPS).

30 Aug 2013

Cancer Therapy News and Research

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Personalized treatment may be effective in wild type cancers

Research finding could lead to better solutions for cancer, anti-viral treatments

Discovery opens doors for developing new therapies to eradicate tumor cells, combat infections

Astrazeneca, Hadasit Launch Drug Discovery Alliance

Novel viral therapy to treat specific types of cancer in children

Biologists identify two pathways via which chromosomes are rearranged

Study suggests expanded screening in younger women greatly reduces breast cancer mortality rate

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

Enzymatics buys Boulder-based ArcherDx

New flexible microneedle patch allows drugs to deliver directly through skin

TSRI scientists identify involvement of angiomotin protein in cancer

Myeloid derived suppressor cells provide niche where cancer stem cells survive

Greenwich Hospital's new radiation oncology therapy gives renewed hope to HRPC patients

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

£13M partnership to accelerate cancer-focused drug discovery launched by Queen's and Almac Discovery

CureDiva announces official launch of online breast cancer solutions store

Scientists identify protein that blocks death of high-risk acute lymphoblastic leukemia cells

Virtual surgical planning technologies for most challenging facial reconstruction cases

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News